RecruitingNCT07229027
Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
Sponsor
Medialis Ltd.
Enrollment
500 participants
Start Date
Nov 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with obesity, overweight and overweight (bmi > 25). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07229027
Related Trials
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
NCT077024611 location
The NTU JO-SMART Study
NCT073173102 locations
Prebiotic Inulin for Late-Reproductive Individuals
NCT077245221 location
Cooking Classes as a Family-based Intervention for Weight Reduction: Effects on Dietary Quality and Weight Management in Abu Dhabi (United Arab Emirates)
NCT076751481 location
Family-Based Weight Wellness Treatment Through Food is Medicine and Group Medical Visits in Pediatric and Adult Primary Care
NCT077176582 locations